Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management.
Zhao EJ, Cheng CV, Mattman A, Chen LYC.
Lancet Haematol. 2021 May;8(5):e365-e375. doi: 10.1016/S2352-3026(21)00056-9.
Polyclonal hypergammaglobulinaemia: towards definition of a threshold.
Baillou C, Jacomet F, Dejoie T, Lureau P, Beuvon C, Grados A, Martins P, Roblot P, Puyade M, Martin M.
Postgrad Med J. 2023 May 22;99(1170):296-301. doi: 10.1136/postgradmedj-2021-140591.
Hypergammaglobulinaemia and autoimmune rheumatic diseases.
Ehrenstein MR, Isenberg DA.
Ann Rheum Dis. 1992 Nov;51(11):1185-7. doi: 10.1136/ard.51.11.1185.
Hypergammaglobulinaemia predicts glandular and extra-glandular damage in primary Sjogren's syndrome: results from the KISS cohort study.
Koh JH, Park Y, Lee J, Park SH, Kwok SK.
Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):114-122. doi: 10.55563/clinexprheumatol/volsh1. Epub 2021 Nov 12.
Primary Sjögren's syndrome.
Bowman SJ.
Lupus. 2018 Oct;27(1_suppl):32-35. doi: 10.1177/0961203318801673.
A novel gain-of-function missense variant in PLCG2 associated with autoinflammation and hypergammaglobulinaemia.
Itakura T, Sasaki H, Hosoya T, Yamaguchi T, Mimori E, Saimon Y, Iwai H, Umezawa N, Kawata D, Kimura N, Kurata M, Shimizu M, Yasuda S.
Rheumatology (Oxford). 2023 Nov 2;62(11):e319-e321. doi: 10.1093/rheumatology/kead193.
[Hypergammaglobulinaemia in cirrhosis (author's transl)].
Fischer D, Paraf A.
Gastroenterol Clin Biol. 1980 Jun-Jul;4(6-7):474-85.
Sjögren's syndrome.
Hughes GR, Whaley K.
Br Med J. 1972 Dec 2;4(5839):533-6. doi: 10.1136/bmj.4.5839.533.
Hyper-IgE syndromes.
Ring J, Landthaler M.
Curr Probl Dermatol. 1989;18:79-88. doi: 10.1159/000416841.
Multiple skin lesions on a background of hypergammaglobulinaemia.
Schauer A, Wood BA, Tan E, Tai A, McLean-Tooke A, Crawford J, Harvey NT.
Clin Exp Dermatol. 2019 Oct;44(7):787-790. doi: 10.1111/ced.13837. Epub 2018 Nov 25.
